Clinical Trial Update: Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease [NA]

View source ↗

Summary

Clinical trial evaluating opicapone as an adjunct to levodopa-carbidopa intestinal gel in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Levodopa-carbidopa intestinal gel (levodopa-carbidopa intestinal gel)
• OpiCapone

Snippet

Sponsor: University Hospital of Ferrara | Conditions: Parkinson Disease, Effect of Drug | NA | Status: COMPLETED